We recently demonstrated that cancer-associated fibroblast (CAF)-derived ANGPTL2 exhibits anti-tumor activities in an AOM/DSS mouse model of colitis-associated colon cancer, in a mouse kidney cancer model, and in murine syngeneic tumor models18,19. This evidence concerns the gene ANGPTL2 and cancer.